These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14769142)

  • 1. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.
    Rogers LR; Remer SE; Tejwani S
    Neuro Oncol; 2004 Jan; 6(1):63-4. PubMed ID: 14769142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine therapy of central nervous system metastases from breast cancer.
    Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
    J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?
    Fabi A; Vidiri A; Ferretti G; Felici A; Papaldo P; Carlini P; Mirri A; Nuzzo C; Cognetti F
    Cancer Invest; 2006; 24(4):466-8. PubMed ID: 16777702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.
    Tham YL; Hinckley L; Teh BS; Elledge R
    Clin Breast Cancer; 2006 Jun; 7(2):164-6. PubMed ID: 16800978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.
    Hikino H; Yamada T; Johbara K; Obayashi N; Ozaki N
    Breast; 2006 Feb; 15(1):97-9. PubMed ID: 16005228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.
    Stemmler HJ; Schmitt M; Harbeck N; Willems A; Bernhard H; Lässig D; Schoenberg S; Heinemann V
    Oncol Rep; 2006 May; 15(5):1373-7. PubMed ID: 16596213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete response of brain metastases originating in breast cancer to capecitabine therapy.
    Siegelmann-Danieli N; Stein M; Bar-Ziv J
    Isr Med Assoc J; 2003 Nov; 5(11):833-4. PubMed ID: 14650117
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancer.
    Amari M; Ishida T; Takeda M; Ohuchi N
    Jpn J Clin Oncol; 2010 Mar; 40(3):188-93. PubMed ID: 19887522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
    Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
    Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer.
    Paydas S; Bicakci K; Yavuz S
    Eur J Intern Med; 2009 Jan; 20(1):96-9. PubMed ID: 19237101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of neoplastic meningitis from solid tumors to oral capecitabine.
    Giglio P; Tremont-Lukats IW; Groves MD
    J Neurooncol; 2003 Nov; 65(2):167-72. PubMed ID: 14686737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
    Osako T; Ito Y; Ushijima M; Takahashi S; Tokudome N; Sugihara T; Iwase T; Matsuura M; Hatake K
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):865-71. PubMed ID: 18670777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of recurrent breast cancer successfully treated with capecitabine monotherapy].
    Mitsuyama S; Anan K; Ono M
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1153-7. PubMed ID: 16121919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
    Fabi A; Metro G; Papaldo P; Mottolese M; Melucci E; Carlini P; Sperduti I; Russillo M; Gelibter A; Ferretti G; Tomao S; Milella M; Cognetti F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):717-25. PubMed ID: 18071704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Lee SJ; Choi YL; Park YH; Kim ST; Cho EY; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):743-51. PubMed ID: 21170649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.
    Venturini M; Paridaens R; Rossner D; Vaslamatzis MM; Nortier JW; Salzberg M; Rodrigues H; Bell R
    Oncology; 2007; 72(1-2):51-7. PubMed ID: 18004077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.
    Stathopoulos GP; Koutantos J; Lazaki H; Rigatos SK; Stathopoulos J; Deliconstantinos G
    Anticancer Res; 2007; 27(3B):1653-6. PubMed ID: 17595791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
    Barrett-Lee P; Bidard FC; Pierga JY
    Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of low-dose capecitabine monotherapy for metastatic breast cancer.
    Taguchi T; Nakayama T; Masuda N; Yoshidome K; Akagi K; Nishida Y; Yoshikawa Y; Ogino N; Abe C; Sakamoto J; Noguchi S;
    Chemotherapy; 2010; 56(2):166-70. PubMed ID: 20407245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.